InvestorsHub Logo
Followers 10
Posts 1765
Boards Moderated 0
Alias Born 09/19/2019

Re: HoldWhatDoor post# 82774

Thursday, 02/11/2021 8:13:54 AM

Thursday, February 11, 2021 8:13:54 AM

Post# of 113847
4 generics waiting for roll out!!!!

? Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer;
? Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer;
? Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer;
? Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)
19

Sunshine Canada is currently in the process of securing a Drug Identification Number (“DIN”) for each of these products from Health
Canada. We are also required to obtain a Drug Establishment License (“DEL”) from Health Canada. Upon receipt of the DEL and DIN’s, we will be
able to accept orders for our own label SBI-Anastrozole, SBI-Letrozole, SBI-Bicalutamide and SBI-Finasteride. We cannot estimate the timing for our
obtaining either the DIN’s or the DEL due to variables involved that are out of our control. Figure 4 shows our 30-Pill blister pack of Anastrozole.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News